In the acquired form of TTP, several risk factors can trigger the formation of antibodies against ADAMTS13 or damage the endothelial cells to liberate a large amount of ultra-large von Willebrand factor. The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.